Beyond statistical significance on isolated endpoints, findings from this umbrella review indicate a shift in the management of metabolic diseases from single-metric control to an integrated, multi-organ and multi-risk-factor strategy
We are not doctors but we are always happy to hear feedback from our customers.
However, studies have shown that GLP-1 may improve insulin sensitivity, activate BAT and reduce adipose tissue inflammation and GCG secretion [4043]
89% were taking lipid-lowering medications including platelet-aggregation inhibitors (77%), ACE inhibitors or angiotensin receptor blockers (79%), and beta blockers (64%)
The referral destination depends on the accompanying findings: liver findings may point to hepatology or gastroenterology, significant kidney disease to nephrology, abnormal counts or smear findings to hematology, and cancer concern to oncology
Mounjaro, which is the brand name of Tirzepatide, is known as a GIP and GLP-1 receptor agonist
